Melzi Surgical Announces Closing of its Series A Financing with Proceeds of Over $4.0 Million
Funds expected to support ramp up of sales network, increase product marketing and enhance the Sharps Finder 2.0Company executing on...
Month: April 2022
Jorge Gomez Joins Moderna as Chief Financial Officer
CAMBRIDGE, MA / ACCESSWIRE / April 11, 2022 / Moderna, Inc., (Nasdaq:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Altamira Therapeutics Announces Peer-Reviewed Publication on Positive in vitro Data with its Bentrio(TM) Drug-Free Nasal Spray Against SARS-CoV-2 Delta Variant
Study Confirms in vitro Efficacy / Safety of Bentrio(TM) for Delta VariantProphylactic treatment of human nasal mucosa with Bentrio™ was...
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill’s Opaganib
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants...
Halberd Entering the Medical Metaverse(TM)
JACKSON CENTER, PA / ACCESSWIRE / April 11, 2022 / Halberd Corporation (OTC PINK:HALB) announces plans to enter the Metaverse...
Zentek Announces Start of Phase Two Testing of ZenGUARD(TM) – Coated Filters Under ISC Testing Stream Contract
GUELPH, ON / ACCESSWIRE / April 11, 2022 / further to its press release dated November 30, 2021, Zentek Ltd....
Moderna Announces First Participants Dosed in Phase 1/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral...
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government
- German government reserves domestic manufacturing capacity until 2029 to ensure rapid access to mRNA vaccines developed by CureVac and...
Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased...
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma...
Chiesi Group Continues to Grow In 2021
Chiesi Group turnover of €2.42bn supported by strong international growth of 8.6%Growth across global markets, with U.S. up more than...
Imprivata Acquires SecureLink to Deliver the Only Single-Vendor Platform to Manage and Secure All Enterprise and Third-Party Digital Identities
Imprivata will unlock further value for customers by unifying, integrating, and automating digital identity to enable autonomous identity systemsWALTHAM, Mass.,...
Editas Medicine Announces Dosing of First Pediatric Patient in the BRILLIANCE Clinical Trial of EDIT-101 for LCA10
Marks the first-ever in vivo delivery of an experimental CRISPR gene editing medicine to a pediatric patient Company on track...
Sidecar Health Launches New Group Fully Insured Health Insurance Product for Employers with 51 or more Employees
Expanding their health insurance offerings, Sidecar Health launches large group health insurance in OhioEL SEGUNDO, Calif., April 11, 2022 (GLOBE...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic...
Dentsply Sirona CFO Jorge Gomez Resigns to Assume CFO Position at Another Public Company
CHARLOTTE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that...
Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service
EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and...
BioCryst to Present at Upcoming Investor Conference
RESEARCH TRIANGLE PARK, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, April 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
ROSELAND, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...